More Impedimed Limited news
Impedimed LimitedASX: IPD

Vanderbilt to Begin Testing Next Generation Device

Jul 17, 2016 at 11:24 PM EDT · Issued by Impedimed Limited

Filed with ASX · Jul 17, 2016 at 11:24 PM EDT

On 6ix: 6ix.com/news/vanderbilt-to-begin-testing-next-generation-device

Watch Impedimed's latest call↗Impedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call↗

Impedimed Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Earlier from Impedimed

  • Medicare Proposes New Reimbursement Rates, L-Dex IncreasesJul 12, 2016
  • Five Year Multi-Location Clinical Trial with Mayo ClinicMay 29, 2016
  • Appendix 4C - Quarter Ended 31 March 2016Apr 19, 2016
  • Strategic RealignmentMar 30, 2016
  • Appendix 4D and Interim Report Ended 31 December 2015Feb 24, 2016

Later from Impedimed

  • Relationship with Redox to Expand EHR Integration CapabilityJul 20, 2016
  • IPD and Mayo Clinic Sign Joint Development AgreementJul 27, 2016
  • Appendix 4C - Quarter Ended 30 June 2016Jul 28, 2016
  • Scripps to use SOZO in Heart Failure StudyAug 9, 2016
  • SOZO Launched - First Product for Health and Wellness MarketAug 11, 2016
All Impedimed news releases↗

Follow Impedimed into a list and get an email when it puts out news.

Follow Impedimed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer